SAWAI GROUP HOLDINGS Co., Ltd.

4887・Prime Market・Pharmaceuticals

Official website

SAWAI GROUP HOLDINGS Co., Ltd.

4887・Prime Market・Pharmaceuticals

Official website

SAWAI GROUP HOLDINGS Co., Ltd.4887

Reference Indicators

Market Cap

1,941¥100M

P/E (Forecast)

—

P/B

1.1x

Dividend Yield (Forecast)

3.33%

ROE

5.8%

EV/EBITDA

8.0x

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	193,816	200,344	176,862	189,024	201,676
Cost of Sales	127,164	137,711	122,543	132,673	142,882
Gross Profit	66,652	62,633	54,319	56,352	58,793
SG&A Expenses	46,690	30,156	23,244	23,518	26,056
Operating Income	-35,888	16,984	18,620	4,050	15,894
Pre-tax Income	-36,214	16,789	18,262	3,161	14,273
Income Taxes	5,710	3,954	5,583	988	2,737
Net Income	-28,269	12,667	13,695	11,969	10,438
EBITDA	-18,843	34,667	36,675	19,291	31,896
Gross Margin	34.4%	31.3%	30.7%	29.8%	29.2%
Operating Margin	-18.5%	8.5%	10.5%	2.1%	7.9%
ROA	-8.1%	3.5%	3.6%	3.4%	2.9%
ROE	-14.9%	6.3%	6.4%	6.9%	5.8%

Segment Performance

Unit: ¥M

2026

Segment	Net Sales	Operating Income	Operating Margin
医薬品等の製造及び販売	0	0	0.0%